Linked Life Data

6452462

Source:http://linkedlifedata.com/resource/pubmed/id/6452462

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1981-6-13
pubmed:abstractText
A method is described for the quantitative analysis in plasma of Ro 10-9359, an aromatic retinoic acid analogue, ethyl all-trans-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoate and its major metabolite Ro 10-1670, all-trans-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,3,6,8-nonatetraenoic acid. The compounds are extracted from patient plasma with diethyl ether, separated on a reversed-phase column and detected and quantified by their UV absorption. The experimental error is below 9% in the concentration range 42-445 ng/ml. The detection limit is about 10 ng/ml. The method was applied to the analysis of plasma levels in healthy volunteers, receiving 75 mg orally.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0021-9673
pubmed:author
pubmed:issnType
Print
pubmed:day
12
pubmed:volume
221
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
345-51
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1980
pubmed:articleTitle
Determination of plasma levels of two aromatic retinoic acid analogues with antipsoriatic activity by high-performance liquid chromatography.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't